Total neoadjuvant FOLFIRINOX or gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2): A nationwide multicenter randomized controlled trial.

Quisette Janssen, Jacob L. van Dam, Marc G. H. Besselink, Marjolein Y. V. Homs, Geertjan van Tienhoven, Johanna W. Wilmink, Bas Groot Koerkamp

Research output: Contribution to journalMeeting AbstractAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Number of pages3
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2021

Cite this